Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
2.
Gastroenterology ; 150(4): 1009-18, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26907603
3.
Health Commun ; 30(12): 1176-80, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26372030

RESUMO

As a field of research, a viable approach to improving health outcomes, and an important area of policy, health literacy has experienced significant growth and considerable evolution since its broad introduction in the 1990s. Despite that history, far too many practitioners, researchers, and policymakers focusing on clinical medicine, health systems, public health, and health policy remain unaware of and unaffected by the best practices of health literacy. While the inherent promise of health literacy is improved health and well-being, the bulk of research has focused on identifying the negative effects of a lack of health literacy. This strategy is a hindrance to further identifying the utility and increasing the uptake of lessons learned about health literacy in government, business, health care systems, and society. The field needs to reverse direction away from that deficit model of health literacy and focus collective efforts on a positive model of how health literacy can and should be prioritized and utilized to improve health at lower costs. This shift from framing health literacy as a problem to proving the viability and strength of health literacy as a solution will present to policymakers a clear choice to either adopt and promote the best practices of health literacy or suffer the consequences of being the leader who ignored a proven, viable solution to the currently unsustainable health care expenditures and ever-increasing burden of preventable disease, disability, and early death.


Assuntos
Letramento em Saúde/organização & administração , Pesquisa/organização & administração , Conscientização , Comportamentos Relacionados com a Saúde , Gastos em Saúde , Nível de Saúde , Humanos , Políticas
4.
Ethn Dis ; 21(3 Suppl 1): S1-100-6, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22352087

RESUMO

OBJECTIVES: Unmet needs for depression and substance abuse services are a concern in urban communities. This article summarizes the design and recommendations of the Restoration Center Planning Project to better address depression and substance abuse while promoting resiliency and wellness for persons of African descent in South Los Angeles. DESIGN: A partnered participatory planning process during 18 months involving community members, faith-based and service agency leaders, and investigators from academic organizations was implemented. Leaders formulated a set of principles to address diversity of the group, hosted community conferences and working groups, while developing recommendations. RESULTS: The community-academic partnership recommended the establishment of restoration centers in Los Angeles (RCLAs) that would serve as a one-stop shop for holistic services addressing depression, substance abuse, related social and spiritual needs, and coordinated care with a network of existing community-based services. Specific recommendations included that the RCs would aim to: 1) support community resilience and improve outcomes for depression and substance abuse; 2) be one-stop shops; 3) promote cultural competency; 4) facilitate ongoing community input and quality review; 5) assure standards of quality within centers and across the broader network; and 6) support the enterprise through a multi-stakeholder community-based board dedicated to RCLA goals. CONCLUSION: A community-academic partnered planning process acknowledged the importance of respect for diversity and formulated plans for the Restoration Center network including the integration of health, social, cultural, and faith-based approaches to services with a multi-agency network and community leadership board. The feasibility of the plan will depend on the subsequent implementation phase.


Assuntos
Negro ou Afro-Americano , Depressão/terapia , Transtornos Relacionados ao Uso de Substâncias/terapia , Pesquisa Participativa Baseada na Comunidade , Depressão/etnologia , Disparidades em Assistência à Saúde , Saúde Holística , Humanos , Los Angeles , Resiliência Psicológica , Transtornos Relacionados ao Uso de Substâncias/etnologia
5.
Ethn Dis ; 21(3 Suppl 1): S1-107-13, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22352088

RESUMO

OBJECTIVE: To conduct a process evaluation of the Restoration Center Los Angeles, a community-academic partnered planning effort aimed at holistically addressing the unmet mental health and substance abuse needs of the Los Angeles African American community. DESIGN: Semi-structured interviews with open-ended questions on key domains of partnership effectiveness were conducted with a random stratified sample of participants varying by level of involvement. PARTICIPANTS: Eleven partners representing grassroots community agencies, faith-based organizations, service providers, and academic institutions. MEASURES: Common themes identified by an evaluation consultant and partners relating to partnership effectiveness, perceived benefits and costs, and future expectations. RESULTS: Findings underscore the importance of considering the potential issues that may arise with the increasing diversity of partners and perspectives. Many of the challenges and facilitating factors that arise within academic-community partnerships were similarly experienced between the diverse set of community partners. Challenges that affected partnership development between community-to-community partners included differences in expectations regarding the final goal of the project, trust-building, and the distribution of funds. Despite such challenges, partners were able to jointly develop a final set of recommendations for the creation of restoration centers, which was viewed as a major accomplishment. CONCLUSIONS: Limited guidance exists on how to navigate differences that arise between community members who have shared identities on some dimensions (eg, African American ethnicity, Los Angeles residence) but divergent identities on other dimensions (eg, formal church affiliation). With increasing diversity of community representation, careful attention needs to be dedicated to not only the development of academic-community partnerships but also community-community partnerships.


Assuntos
Pesquisa Participativa Baseada na Comunidade/organização & administração , Relações Interprofissionais , Negro ou Afro-Americano , Disparidades em Assistência à Saúde , Humanos , Los Angeles , Saúde Mental , Desenvolvimento de Programas , Religião , Transtornos Relacionados ao Uso de Substâncias/prevenção & controle , Universidades
6.
Value Health ; 11(2): 131-8, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18380625

RESUMO

OBJECTIVE: In Taiwan, the carrier rate of hepatitis B surface antigen is 15% to 20%, one of the highest in the world. Among chronic hepatitis B (CHB) patients, hepatitis B e antigen (HBeAg)-negative accounts for approximately 40% to 50% of these patients. A recent study found that peginterferon alfa-2a (40 KD) is more effective than lamivudine in treating HBeAg-negative CHB, but its cost-effectiveness has not been evaluated. Our objective is to evaluate the incremental cost-effectiveness of 48 weeks of peginterferon alfa-2a compared to 48 weeks of lamivudine, from the perspective of the Taiwan Bureau of National Health Insurance. METHODS: A Markov model was used to simulate the natural history of HBeAg-negative CHB in a cohort of 40-year-old patients. Efficacy, disease progression, economic, and quality-of-life data were derived from published literature and a survey of clinical experts in Taiwan. Life expectancy, quality-adjusted life expectancy, lifetime costs in New Taiwan Dollars (NTD) (1 USD = 31.96 NTD), and incremental cost-effectiveness ratios (ICERs) were calculated. RESULTS: The gain in quality-adjusted life-years (QALYs) for 48 weeks of peginterferon alfa-2a compared to 48 weeks of lamivudine was 0.45 at an additional cost of 157,000 NTD (4900 USD), resulting in an ICER of 347,000 NTD (10,900 USD) per QALY gained. The 95% central range for the ICER from a probabilistic sensitivity analysis was 228,000-566,000 NTD (7100-17,700 USD). CONCLUSIONS: In HBeAg-negative CHB, 48 weeks of treatment with peginterferon alfa-2a compared to 48 weeks of lamivudine appears to offer life expectancy and quality-of-life improvements at an acceptable cost-effectiveness ratio.


Assuntos
Antivirais/economia , Hepatite B Crônica/tratamento farmacológico , Hepatite B Crônica/economia , Interferon-alfa/economia , Lamivudina/economia , Polietilenoglicóis/economia , Antivirais/uso terapêutico , Análise Custo-Benefício , Custos de Cuidados de Saúde/estatística & dados numéricos , Antígenos E da Hepatite B/sangue , Humanos , Interferon alfa-2 , Interferon-alfa/uso terapêutico , Lamivudina/uso terapêutico , Cadeias de Markov , Programas Nacionais de Saúde/economia , Polietilenoglicóis/uso terapêutico , Anos de Vida Ajustados por Qualidade de Vida , Proteínas Recombinantes , Taiwan
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA